Program for RNA Biology, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA.
Immunol Rev. 2013 May;253(1):97-111. doi: 10.1111/imr.12053.
RNA interference (RNAi) is an ancient process by which non-coding RNAs regulate gene expression in a sequence-specific manner. The core components of RNAi are small regulatory RNAs, approximately 21-30 nucleotides in length, including small interfering RNAs (siRNAs) and microRNAs (miRNAs). The past two decades have seen considerable progress in our understanding of the molecular mechanisms underlying the biogenesis of siRNAs and miRNAs. Recent advances have also revealed the crucial regulatory roles played by small RNAs in such diverse processes as development, homeostasis, innate immunity, and oncogenesis. Accumulating evidence indicates that RNAi initially evolved as a host defense mechanism against viruses and transposons. The ability of the host small RNA biogenesis machinery to recognize viral double-stranded RNA replication intermediates and transposon transcripts is critical to this process, as is small RNA-guided targeting of RNAs via complementary base pairing. Collectively, these properties confer unparalleled specificity and precision to RNAi-mediated gene silencing as an effective antiviral mechanism.
RNA 干扰 (RNAi) 是一种古老的过程,通过该过程非编码 RNA 以序列特异性方式调节基因表达。RNAi 的核心组件是小调节 RNA,其长度约为 21-30 个核苷酸,包括小干扰 RNA (siRNA) 和 microRNA (miRNA)。在过去的二十年中,我们对 siRNA 和 miRNA 生物发生的分子机制有了相当大的了解。最近的进展还揭示了小 RNA 在发育、内稳态、先天免疫和肿瘤发生等多种过程中发挥的关键调节作用。越来越多的证据表明,RNAi 最初是作为一种宿主防御机制进化而来的,以抵御病毒和转座子。宿主小 RNA 生物发生机制识别病毒双链 RNA 复制中间体和转座子转录本的能力对这一过程至关重要,小 RNA 通过互补碱基配对引导 RNA 的靶向也是如此。总的来说,这些特性使 RNAi 介导的基因沉默作为一种有效的抗病毒机制具有无与伦比的特异性和精度。